Business Context and Reporting Period
This Form 6-K filing is submitted by FSD Pharma Inc. (noted as Quantum Biopharma Ltd. in request metadata) for the month of January 2022, dated January 17, 2022. The registrant is a foreign private issuer based in Toronto, Ontario, Canada, and files annual reports under Form 40-F.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report serves as a disclosure of a corporate event rather than a financial statement.
Material Changes
No material financial changes versus the prior comparable period are reported in this document.
Management Commentary and Corporate Events
- Corporate Recognition: The filing includes a press release (Exhibit 99.1) dated January 18, 2022, announcing that Dr. Eleanor Fish has been named to the Order of Canada.
- Management: The report was signed by Nathan Coyle, Chief Financial Officer.
Investor Verification Checklist
- Verify the full text of the press release regarding Dr. Eleanor Fish's appointment to the Order of Canada.
- Confirm the company's current ticker symbol and name, as the request metadata lists "Quantum Biopharma Ltd." while the filing identifies "FSD Pharma Inc."
- Review the most recent Form 40-F or 20-F for actual financial performance data, as this 6-K contains no financial figures.